Board of the Centers for Control and Prevention
The United States has Approved a Third Dose of the Pfizer Vaccine for People Over 65
It will be implemented at least six months after the second
The US Food and Drug Administration has supported the use of a booster dose of Pfizer's COVID-19 vaccine for people over the age of 65 and for some high-risk patients. The decision is to be voted on by the Board of the Centers for Control and Prevention. Most likely this will happen today.